Press releases

Latest news

Nomination Committee for the CellaVision Annual General Meeting 2023

Ahead of the Annual General Meeting 2023, the Nomination Committee consists of:Christer Fåhraeus, Christer Fåhraeus with...

On track despite challenging conditions in the quarter

Organic sales growth: Q3, 2022: -3% (52)EBITDA margin:Q3, 2022: 21% (32)Summary, July 1-September 30, 2022Net sales...

Invitation to presentation of the CellaVision report for the third quarter 2022 on October 26, at 11:00 CEST

CellaVision AB (publ) will publish the Interim report for the third quarter, on October 26, 2022 at 7:20 CEST. The...

CellaVision® launches a complete workflow solution for low-volume hematology laboratories

On July 27, 2022, CellaVision® announces the launch of DIFF-Line ™ by CellaVision, a new workflow solution for low...

Best quarter yet. Sales reaching all-time high

April 1-June 30, 2022Net sales increased by 36% to SEK 184 million (135).Sales increased organically by 28% (23)...

Invitation to presentation of the CellaVision report for the second quarter 2022 on July 20, at 11:00 CEST

CellaVision AB (publ) will publish the Interim report for the second quarter, on July 20, 2022 at 7:20 CEST. The report...

Invitation to CellaVision Capital Markets Day 2022

CellaVision invites institutional investors, financial analysts and media to join its Capital Markets Day on June 16...

Bulletin from the Annual General Meeting of CellaVision AB (publ)

The following resolutions were passed at the Annual General Meeting (the “AGM”) of CellaVision AB (publ) (“CellaVision”)...

Learn more

Reports & presentations

Here you will find earlier and current CellaVision interim and annual reports. They are available for download in PDF format, in English and Swedish.

Key figures

Here you can view and download financial data for CellaVision.

About us

We help hematology laboratories automate and simplify the process of performing blood and body fluid differentials.